Jonathan Burr
Chief Commercial Officer @Humaneva Group
Signup · Get unlimited contacts
WORK HISTORY
Chief Commercial Officer @Humaneva Group
Leads global commercial strategy, enterprise partnerships, and growth across the Humaneva platform, including business development, key accounts, and integrated service offerings across international markets.Humaneva Group is a private equity-backed clinical development organization delivering integrated trial execution across services, sites, and technology. The group combines Kapadi (full-service CRO and study delivery), Pratia (international investigative site network and patient access), and Hyggio (clinical technology and study workflow platform). Together, the platform unifies sponsors, sites, and data within a single operating model to improve enrollment performance, operational predictability, and end-to-end clinical trial execution for biopharma and biotech sponsors.
SKILLS
ABOUT JONATHAN BURR
I work at the intersection of clinical development, operating model design, and commercial strategy. My focus is on how the industry can move beyond fragmented service models and build integrated platforms that bring together study delivery, investigative sites, and enabling technology. As trials become more complex, distributed, and data-intensive, sponsors increasingly need partners who can execute across operations, patients, and technology in a coordinated way. I am currently Chief Commercial Officer at Humaneva Group, a private equity-backed clinical development platform combining Kapadi (full-service CRO), Pratia (international investigative site network), and Hyggio (clinical technology). My role is to lead global commercial strategy, enterprise partnerships, and growth across the integrated platform, supporting sponsors in delivering faster, more predictable clinical programs. Over the past twenty years, I have led commercial, data, and technology organizations across the life sciences ecosystem. At Cytel, I oversaw global sales, marketing, and commercial operations, bringing advanced analytics, adaptive design, and AI-driven approaches into enterprise pharma conversations. Prior to that, I held senior leadership roles at Saama, Clario, and Accenture, helping scale clinical technology platforms, reshape go-to-market strategy, and support private equity value creation. Throughout my career, my motivation has remained consistent: to help life sciences organizations modernize how trials are designed and delivered. I believe the next major shift in clinical development will come from tighter integration across CRO execution, site performance, and intelligent technology, supported by data science and AI. I welcome conversations with sponsors, biotech innovators, investors, and partners who are focused on building the next generation of clinical development.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.